In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Inivata raises £31.5mm through Series A round

Executive Summary

Cancer genomics firm Inivata Ltd. raised £31.5mm ($45mm) through its Series A round from existing investors Imperial Innovations, Cambridge Innovation Capital, and Johnson & Johnson Innovation – Johnson & Johnson Development Corp. (JJDC). New buyer Woodford Patient Capital Trust (a fund managed by Woodford Investment Management) also participated.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register